These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27770451)

  • 1. Frequency of fetal karyotype abnormalities in women undergoing invasive testing in the absence of ultrasound and other high-risk indications.
    Ferreira JC; Grati FR; Bajaj K; Malvestiti F; Grimi MB; Trotta A; Liuti R; Milani S; Branca L; Hartman J; Maggi F; Simoni G; Gross SJ
    Prenat Diagn; 2016 Dec; 36(12):1146-1155. PubMed ID: 27770451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal karyotyping after 28 weeks of gestation for late ultrasound findings in a low risk population.
    Drummond CL; Gomes DM; Senat MV; Audibert F; Dorion A; Ville Y
    Prenat Diagn; 2003 Dec; 23(13):1068-72. PubMed ID: 14691994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based trends in invasive prenatal diagnosis for ultrasound-based indications: two decades of change from 1994 to 2016.
    Lostchuck E; Poulton A; Halliday J; Hui L
    Ultrasound Obstet Gynecol; 2019 Apr; 53(4):503-511. PubMed ID: 29877030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Karyotype analysis of amniotic fluid cells and comparison of chromosomal abnormality rate during second trimester].
    Zhang YP; Wu JP; Li XT; Lei CX; Xu JZ; Yin M
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):644-8. PubMed ID: 22176986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry.
    Verdin SM; Whitlow BJ; Lazanakis M; Kadir RA; Chatzipapas I; Economides DL
    Ultrasound Obstet Gynecol; 2000 Oct; 16(5):402-6. PubMed ID: 11169322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indications for genetic amniocentesis investigated at the Department of Gynecology, Obstetrics, and Oncologic Gynecology, Nicolaus Copernicus University, Collegium Medicum, Bydgoszcz].
    Sadłecki P; Walentowicz-Sadłecka M; Pasińska M; Adamczak R; Grabiec M
    Ginekol Pol; 2014 Jun; 85(6):420-3. PubMed ID: 25029805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal and postnatal findings in small-for-gestational-age fetuses without structural ultrasound anomalies at 18-24 weeks.
    de Wit MC; Srebniak MI; Joosten M; Govaerts LC; Kornelisse RF; Papatsonis DN; de Graaff K; Knapen MF; Bruggenwirth HT; de Vries FA; Van Veen S; Van Opstal D; Galjaard RJ; Go AT
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):342-348. PubMed ID: 27102944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases.
    Nyberg DA; Luthy DA; Resta RG; Nyberg BC; Williams MA
    Ultrasound Obstet Gynecol; 1998 Jul; 12(1):8-14. PubMed ID: 9697277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].
    Hou QF; Wu D; Chu Y; Kang B; Liao SX; Yang YL; Zhang CY; Zhang JX; Wu G
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):813-7. PubMed ID: 23302120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
    Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trisomies and other chromosome abnormalities detected after positive sonographic findings.
    Beke A; Papp C; Tóth-Pál E; Mezei G; Joó JG; Csaba A; Papp Z
    J Reprod Med; 2005 Sep; 50(9):675-91. PubMed ID: 16363756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between prenatal atrioventricular septal defects and chromosomal abnormalities.
    Morlando M; Bhide A; Familiari A; Khalil A; Morales-Roselló J; Papageorghiou AT; Carvalho JS
    Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():31-35. PubMed ID: 27888703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
    Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
    Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chorionic villus sampling in the cell-free DNA aneuploidy screening era: careful selection criteria can maximise the clinical utility of screening and invasive testing.
    Kane SC; Reidy KL; Norris F; Nisbet DL; Kornman LH; Palma-Dias R
    Prenat Diagn; 2017 Apr; 37(4):399-408. PubMed ID: 28207933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal diagnosis of Pallister-Killian syndrome in pregnancy with normal CVS result and abnormal ultrasound findings in the second trimester.
    Frisova V; Svobodova IT; Tozzi M; Raskova D
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):726-729. PubMed ID: 30342660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-trimester ultrasound screening for fetal aneuploidies in women over 35 and under 35 years of age.
    Szabó J; Gellén J; Szemere G
    Ultrasound Obstet Gynecol; 1995 Mar; 5(3):161-3. PubMed ID: 7788489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal cytogenetic diagnosis study of 2782 cases of high-risk pregnant women.
    Zhang L; Zhang XH; Liang MY; Ren MH
    Chin Med J (Engl); 2010 Feb; 123(4):423-30. PubMed ID: 20193481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical features of abnormal chromosome karyotypes in twin pregnancies complicated with structural abnormalities].
    Zhong SL; Fang Q; Chen BJ; Han ZY; Luo YM; Chen JS; Xie YJ
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):649-54. PubMed ID: 22176987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X; Chang Y; Cui HY; Ren CC; Yu BY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical approach to prenatal diagnosis of chromosome abnormalities].
    Herlicoviez M
    Reprod Nutr Dev; 1990; Suppl 1():139s-145s. PubMed ID: 2206291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.